It has been reported that NUPR1 is involved in chemoresistance in breast and pancreatic cancers.38, 39 Here we demonstrated that NUPR1 depletion led to a significant increase in HCC cell sensitivity to sorafenib treatment, suggesting that it may also have a pivotal role in HCC chemoresistance. Here, NUPR1 is linked to hepatocellular carcinoma.